Involvement in technology transfer
IGBMC holds a portfolio of about 30 patents, know-how and software subject to transfer to socio-economic partners. It is possible to acquire a license to develop and industrialize the technology within your company.
In order to promote technology transfer, the IGBMC works in collaboration with CONECTUS, a technology transfer office (TTO) launched as part of the Programme d'investissement avenir (PIA) financing tool.
Examples of technology transfer led by IGBMC
IGBMC imaging facility has developed a fluorescence macroscope (MacroFluo™) as well as a confocal macroscope (Macroconfocal Leica TCS MSI) that have been commercialized worldwide through a partnership with Leica Microsystems.
The French biotech company LYSOGENE has an exclusive worldwide license agreement to develop a gene therapy drug candidate for the treatment of Fragile X syndrome.